ConductScience.org, home

Paper17575233

AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis.

Wilkinson RW and 18 others. Clin Cancer Res, 2007. Cited by 311 papers, by iCite.

Cite this record

ConductScience Library. AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis. Papers, record 17575233. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17575233

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis.
PubMed
Journal
Clin Cancer Res
PubMed
Year
2007
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
311
iCite
Relative citation ratio, by iCite
6.05
iCite
Revised in PubMed
2021-12-03
PubMed

Authors19

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wilkinson RWRobert W
2Odedra RRajesh
3Heaton SPSimon P
4Wedge SRStephen R
5Keen NJNicholas J
6Crafter CClaire
7Foster JRJohn R
8Brady MCMadeleine C
9Bigley AAlison
10Brown EElaine
11Byth KFKate F
12Barrass NCNigel C
13Mundt KEKirsten E
14Foote KMKevin M
15Heron NMNicola M
16Jung FHFrederic H
17Mortlock AAAndrew A
18Boyle FTF Thomas
19Green SStephen

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
ApoptosisMajor topic
Neoplasms, ExperimentalMajor topic
OrganophosphatesMajor topic
QuinazolinesMajor topic
Animals
Aurora Kinase B
Aurora Kinases
Cell Line, Tumor
Cell Proliferation
Flow Cytometry
Humans
Mice
Mice, Nude
Protein Serine-Threonine Kinases
Rats
Transplantation, Heterologous

Source PubMed

Download CSV of topics

Cited by164

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 311 citations.

PMIDTitleJournalYearIn PapersSource
42028206Discovery of thieno[2,3-d]pyrimidine-based dual Aurora B/VEGFR-2 inhibitors with potent anticancer activity: molecular docking, mechanistic studies, and in vivo validation in a breast cancer model.RSC Adv2026https://conductscience.org/library/papers/42028206PubMed
41813673Tumour specific HORMAD1 expression perturbs mitotic arrest and drives sensitivity to mitotic kinase inhibitors.Nat Commun2026https://conductscience.org/library/papers/41813673PubMed
41540256Chromosome length is constrained by spindle scaling to ensure faithful mitosis in mammals.Mol Syst Biol2026https://conductscience.org/library/papers/41540256PubMed
41357898Structure-based identification of Jervine as a potent dual-targeting inhibitor of cell cycle kinases.Front Pharmacol2025https://conductscience.org/library/papers/41357898PubMed
41159445KLHL13 functional defects cause neurodevelopmental disorder in humans that can be rescued via inhibition of AURKB in cellular and animal models.Genet Med2026https://conductscience.org/library/papers/41159445PubMed
41089486Discovery of a Potent and Highly Selective Inhibitor of Aurora A Kinase.ACS Med Chem Lett2025https://conductscience.org/library/papers/41089486PubMed
41037662Epigenetic and Transcriptional Programs Define Osteosarcoma Subtypes and Establish Targetable Vulnerabilities.Cancer Discov2026https://conductscience.org/library/papers/41037662PubMed
40822359AURKB and PI3K/AKT/mTOR pathways converge to regulate TERT expression.iScience2025https://conductscience.org/library/papers/40822359PubMed
40740243The Traditional Chinese Medicine Formula Modified Wu Bao San Induces Cell Cycle Arrest and Apoptosis through Restoration of Retinoblastoma Protein Function and Inhibition of Aurora Kinase Activity.J Cancer2025https://conductscience.org/library/papers/40740243PubMed
40481349The expression and prognosis for Aurora kinases in human non-small cell lung cancer.Discov Oncol2025https://conductscience.org/library/papers/40481349PubMed
39933527Unraveling AURKB as a potential therapeutic target in pulmonary hypertension using integrated transcriptomic analysis and pre-clinical studies.Cell Rep Med2025https://conductscience.org/library/papers/39933527PubMed
39932274Functional Profiling of p53 and RB Cell Cycle Regulatory Proficiency Suggests Mechanism-Driven Molecular Stratification in Endometrial Carcinoma.Cancer Res Commun2025https://conductscience.org/library/papers/39932274PubMed
39073155Haspin mediates H3.3S31 phosphorylation downstream of Aurora B in mouse embryonic stem cells.Protein Sci2024https://conductscience.org/library/papers/39073155PubMed
38315003Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy.Cancer Discov2024https://conductscience.org/library/papers/38315003PubMed
37443114BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors.Mol Cancer2023https://conductscience.org/library/papers/37443114PubMed
37289191Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer.Clin Cancer Res2023https://conductscience.org/library/papers/37289191PubMed
37230964An Aurora B-RPA signaling axis secures chromosome segregation fidelity.Nat Commun2023https://conductscience.org/library/papers/37230964PubMed
36902447Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent Glioblastomas.Int J Mol Sci2023https://conductscience.org/library/papers/36902447PubMed
36515566A theory of rapid evolutionary change explaining the de novo appearance of megakaryocytes and platelets in mammals.J Cell Sci2022https://conductscience.org/library/papers/36515566PubMed
36497287The Aurora Kinase Inhibitor TAK901 Inhibits Glioblastoma Growth by Blocking SREBP1-Mediated Lipid Metabolism.Cancers (Basel)2022https://conductscience.org/library/papers/36497287PubMed

See all 164 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
AURKB9212PubTator's text mininghttps://conductscience.org/library/genes/9212

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17575233

GET https://conductscience.org/api/papers/v1/17575233/cited_by?page=2